Global Orthobiologics Market 2018-2022
出 版 商：Technavio
出版日期：2018/07/18
頁 數：101頁
文件格式：PDF
價 格：
USD 2,500 (Single-User License)
USD 3,000 (Multi-User License)
USD 4,000 (Global-User License)
USD 3,000 (Multi-User License)
USD 4,000 (Global-User License)
About Orthobiologics
Orthobiologics are made with substances found naturally in the human body and are used for treating orthopaedic diseases. They are used for swift healing, faster recovery, and fewer hospital visits.
Technavio’s analysts forecast the global orthobiologics market to grow at a CAGR of 7.01% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global orthobiologics market for 2018-2022. To calculate the market size, the report considers the revenue generated from the use of bone graft substitutes, visco supplementation, and stem cells across application segments including spinal fusion, reconstructive surgery, and trauma repair.
The market is divided into the following segments based on geography:
‧ Americas
‧ APAC
‧ EMEA
Technavio's report, Global Orthobiologics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
‧ Arthrex
‧ Bioventus
‧ Johnson & Johnson Services
‧ Medtronic
‧ Stryker
Market driver
‧ Increase in focus to reduce orthopaedic surgeries
‧ For a full, detailed list, view our report
Market challenge
‧ Concerns associated with the use of orthobiologics
‧ For a full, detailed list, view our report
Market trend
‧ Emerging technological innovations
‧ For a full, detailed list, view our report
Key questions answered in this report
‧ What will the market size be in 2022 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Orthobiologics are made with substances found naturally in the human body and are used for treating orthopaedic diseases. They are used for swift healing, faster recovery, and fewer hospital visits.
Technavio’s analysts forecast the global orthobiologics market to grow at a CAGR of 7.01% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global orthobiologics market for 2018-2022. To calculate the market size, the report considers the revenue generated from the use of bone graft substitutes, visco supplementation, and stem cells across application segments including spinal fusion, reconstructive surgery, and trauma repair.
The market is divided into the following segments based on geography:
‧ Americas
‧ APAC
‧ EMEA
Technavio's report, Global Orthobiologics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
‧ Arthrex
‧ Bioventus
‧ Johnson & Johnson Services
‧ Medtronic
‧ Stryker
Market driver
‧ Increase in focus to reduce orthopaedic surgeries
‧ For a full, detailed list, view our report
Market challenge
‧ Concerns associated with the use of orthobiologics
‧ For a full, detailed list, view our report
Market trend
‧ Emerging technological innovations
‧ For a full, detailed list, view our report
Key questions answered in this report
‧ What will the market size be in 2022 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
‧ Market ecosystem
‧ Market characteristics
‧ Market segmentation analysis
PART 05: MARKET SIZING
‧ Market definition
‧ Market sizing 2017
‧ Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
‧ Bargaining power of buyers
‧ Bargaining power of suppliers
‧ Threat of new entrants
‧ Threat of substitutes
‧ Threat of rivalry
‧ Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
‧ Segmentation by product
‧ Comparison by product
‧ Bone graft substitutes market – Market size and forecast 2017-2022
‧ Viscosupplementation market – Market size and forecast 2017-2022
‧ Stem cells market – Market size and forecast 2017-2022
‧ Market opportunity by product
PART 08: MARKET SEGMENTATION BY APPLICATION
‧ Segmentation by application
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
‧ Geographical segmentation
‧ Regional comparison
‧ Orthobiologics market in Americas – Market size and forecast 2017-2022
‧ Orthobiologics market in EMEA – Market size and forecast 2017-2022
‧ Orthobiologics market in APAC – Market size and forecast 2017-2022
‧ Key leading countries
‧ Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
‧ Market drivers
‧ Market challenges
PART 13: MARKET TRENDS
‧ Increase in development of new products
‧ Emerging technological innovations
‧ Rise in popularity of orthobiologics
PART 14: VENDOR LANDSCAPE
‧ Overview
‧ Landscape disruption
PART 15: VENDOR ANALYSIS
‧ Vendors covered
‧ Vendor classification
‧ Market positioning of vendors
‧ Arthrex
‧ Bioventus
‧ Johnson & Johnson Services
‧ Medtronic
‧ Stryker
PART 16: APPENDIX
‧ List of abbreviations
Exhibit 01: Related market
Exhibit 02: Market characteristics
Exhibit 03: Market segments
Exhibit 04: Market definition - Inclusions and exclusions checklist
Exhibit 05: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global orthobiologics market – Market size and forecast 2017-2022 ($ mn)
Exhibit 08: Global orthobiologics market – Year-over-year growth 2018-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2017
Exhibit 17: Global orthobiologics market – Market share by product 2017-2022 (%)
Exhibit 18: Comparison by product
Exhibit 19: Bone graft substitutes market – Market size and forecast 2017-2022 ($ mn)
Exhibit 20: Bone graft substitutes market – Year-over-year growth 2018-2022 (%)
Exhibit 21: Viscosupplementation market – Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Viscosupplementation market – Year-over-year growth 2018-2022 (%)
Exhibit 23: Stem cells market – Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Stem cells market – Year-over-year growth 2018-2022 (%)
Exhibit 25: Market opportunity by product
Exhibit 26: Customer landscape
Exhibit 27: Global orthobiologics market – Market share by geography 2017-2022 (%)
Exhibit 28: Regional comparison
Exhibit 29: Orthobiologics market in Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 30: Orthobiologics market in Americas – Year-over-year growth 2018-2022 (%)
Exhibit 31: Orthobiologics market in EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: Orthobiologics market in EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 33: Orthobiologics market in APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 34: Orthobiologics market in APAC – Year over year growth 2018-2022 (%)
Exhibit 35: Key leading countries
Exhibit 36: Market opportunity
Exhibit 37: Vendor landscape
Exhibit 38: Landscape disruption
Exhibit 39: Vendors covered
Exhibit 40: Vendor classification
Exhibit 41: Market positioning of vendors
Exhibit 42: Arthrex -overview
Exhibit 43: Arthrex – Business segments
Exhibit 44: Arthrex – Organizational developments
Exhibit 45: Arthrex – Key offerings
Exhibit 46: Bioventus - overview
Exhibit 47: Bioventus – Business segments
Exhibit 48: Bioventus – Organizational developments
Exhibit 49: Bioventus – Key offerings
Exhibit 50: Johnson & Johnson Services -overview
Exhibit 51: Johnson & Johnson Services – Business segments
Exhibit 52: Johnson & Johnson Services – Organizational developments
Exhibit 53: Johnson & Johnson Services – Geographic focus
Exhibit 54: Johnson & Johnson Services – Segment focus
Exhibit 55: Johnson & Johnson Services – Key offerings
Exhibit 56: Medtronic -overview
Exhibit 57: Medtronic – Business segments
Exhibit 58: Medtronic – Organizational developments
Exhibit 59: Medtronic – Geographic focus
Exhibit 60: Medtronic – Segment focus
Exhibit 61: Medtronic – Key offerings
Exhibit 62: Stryker -overview
Exhibit 63: Stryker – Business segments
Exhibit 64: Stryker – Organizational developments
Exhibit 65: Stryker – Geographic focus
Exhibit 66: Stryker – Segment focus
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
‧ Market ecosystem
‧ Market characteristics
‧ Market segmentation analysis
PART 05: MARKET SIZING
‧ Market definition
‧ Market sizing 2017
‧ Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
‧ Bargaining power of buyers
‧ Bargaining power of suppliers
‧ Threat of new entrants
‧ Threat of substitutes
‧ Threat of rivalry
‧ Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
‧ Segmentation by product
‧ Comparison by product
‧ Bone graft substitutes market – Market size and forecast 2017-2022
‧ Viscosupplementation market – Market size and forecast 2017-2022
‧ Stem cells market – Market size and forecast 2017-2022
‧ Market opportunity by product
PART 08: MARKET SEGMENTATION BY APPLICATION
‧ Segmentation by application
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
‧ Geographical segmentation
‧ Regional comparison
‧ Orthobiologics market in Americas – Market size and forecast 2017-2022
‧ Orthobiologics market in EMEA – Market size and forecast 2017-2022
‧ Orthobiologics market in APAC – Market size and forecast 2017-2022
‧ Key leading countries
‧ Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
‧ Market drivers
‧ Market challenges
PART 13: MARKET TRENDS
‧ Increase in development of new products
‧ Emerging technological innovations
‧ Rise in popularity of orthobiologics
PART 14: VENDOR LANDSCAPE
‧ Overview
‧ Landscape disruption
PART 15: VENDOR ANALYSIS
‧ Vendors covered
‧ Vendor classification
‧ Market positioning of vendors
‧ Arthrex
‧ Bioventus
‧ Johnson & Johnson Services
‧ Medtronic
‧ Stryker
PART 16: APPENDIX
‧ List of abbreviations
Exhibit 01: Related market
Exhibit 02: Market characteristics
Exhibit 03: Market segments
Exhibit 04: Market definition - Inclusions and exclusions checklist
Exhibit 05: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global orthobiologics market – Market size and forecast 2017-2022 ($ mn)
Exhibit 08: Global orthobiologics market – Year-over-year growth 2018-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2017
Exhibit 17: Global orthobiologics market – Market share by product 2017-2022 (%)
Exhibit 18: Comparison by product
Exhibit 19: Bone graft substitutes market – Market size and forecast 2017-2022 ($ mn)
Exhibit 20: Bone graft substitutes market – Year-over-year growth 2018-2022 (%)
Exhibit 21: Viscosupplementation market – Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Viscosupplementation market – Year-over-year growth 2018-2022 (%)
Exhibit 23: Stem cells market – Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Stem cells market – Year-over-year growth 2018-2022 (%)
Exhibit 25: Market opportunity by product
Exhibit 26: Customer landscape
Exhibit 27: Global orthobiologics market – Market share by geography 2017-2022 (%)
Exhibit 28: Regional comparison
Exhibit 29: Orthobiologics market in Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 30: Orthobiologics market in Americas – Year-over-year growth 2018-2022 (%)
Exhibit 31: Orthobiologics market in EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: Orthobiologics market in EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 33: Orthobiologics market in APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 34: Orthobiologics market in APAC – Year over year growth 2018-2022 (%)
Exhibit 35: Key leading countries
Exhibit 36: Market opportunity
Exhibit 37: Vendor landscape
Exhibit 38: Landscape disruption
Exhibit 39: Vendors covered
Exhibit 40: Vendor classification
Exhibit 41: Market positioning of vendors
Exhibit 42: Arthrex -overview
Exhibit 43: Arthrex – Business segments
Exhibit 44: Arthrex – Organizational developments
Exhibit 45: Arthrex – Key offerings
Exhibit 46: Bioventus - overview
Exhibit 47: Bioventus – Business segments
Exhibit 48: Bioventus – Organizational developments
Exhibit 49: Bioventus – Key offerings
Exhibit 50: Johnson & Johnson Services -overview
Exhibit 51: Johnson & Johnson Services – Business segments
Exhibit 52: Johnson & Johnson Services – Organizational developments
Exhibit 53: Johnson & Johnson Services – Geographic focus
Exhibit 54: Johnson & Johnson Services – Segment focus
Exhibit 55: Johnson & Johnson Services – Key offerings
Exhibit 56: Medtronic -overview
Exhibit 57: Medtronic – Business segments
Exhibit 58: Medtronic – Organizational developments
Exhibit 59: Medtronic – Geographic focus
Exhibit 60: Medtronic – Segment focus
Exhibit 61: Medtronic – Key offerings
Exhibit 62: Stryker -overview
Exhibit 63: Stryker – Business segments
Exhibit 64: Stryker – Organizational developments
Exhibit 65: Stryker – Geographic focus
Exhibit 66: Stryker – Segment focus
